Anupam Rasayan India Ltd.

NSE: ANURAS

NIFTY500

Analyst consensus:Cautious· 7 analysts

₹1,281.10+13.1%1Y

Last updated 03:00:21 IST· Public market feed (~15 min delay during market hours)

Anupam Rasayan India Ltd.: A 30-second snapshot

Anuras Industries (Chemicals) trades at ₹1,376, up 53.4% over 12 months, with a trailing PE of 89.2 and forward PE of 62.7 — the most expensive valuation in its 6-stock sector peer group. The company has delivered 5-year revenue CAGR of 31.3% and earnings CAGR of 67.7%, but carries a debt-to-equity of 37.5 (rising trend) with FCF positive in only 1 of the available historical years.

P/E

89.2

Forward P/E

62.7

ROE

—

Debt / Equity

37.51

Profit Margin

+7.7%

Div. Yield

+0.1%

5Y ROE > 15%

0/5

5Y FCF > 0

1/5

Quality

37/100

Recent context

·No news articles were collected for this run (0 of 0), so there is no current information on contracts, management commentary, regulatory developments, or sector-level catalysts specific to ANURAS.
·Nearest technical resistance levels are ₹1,384, ₹1,407, and ₹1,415; the stock is currently at ₹1,376, approximately 0.6% below the closest resistance zone.
·Analyst coverage includes 7 analysts but no consensus rating is available in this dataset, limiting visibility into institutional sentiment.

Strengths

+5-year revenue CAGR of 31.3% and earnings CAGR of 67.7% are the highest growth rates visible in the Chemicals peer dataset, outpacing PIDILITIND, SOLARINDS, COROMANDEL, PI Industries, and SRF.
+Price is 13.2% above its 200-DMA (₹1,214) and 6.6% above its 50-DMA (₹1,291), with a 52-week drawdown of only -2.76% — technically, the stock has held close to its annual high.
+RSI of 65.2 is in the upper-neutral zone, indicating momentum without the extreme readings (>75) associated with near-term technical exhaustion.
+Forward PE of 62.7 versus trailing PE of 89.2 implies market expectations of approximately 42% near-term earnings growth, consistent with the historical earnings CAGR trajectory.

Weaknesses

−D/E of 37.5 is by far the highest leverage ratio in the peer group and the debt trend is rising — a sustained deterioration in operating conditions could compress interest coverage and challenge debt servicing.
−FCF was positive in only 1 of the available historical years; without consistent free cash generation, the company is reliant on external financing to fund growth, amplifying balance-sheet risk.
−ROE has never exceeded 15% in the available data (0 years above threshold) and the overall consistency score is 4, indicating that high earnings growth has not produced durable returns on equity capital.
−At a trailing PE of 89.2 — highest among 6 peers — the valuation premium leaves little margin for earnings disappointment; a single-quarter miss or guidance revision could produce a sharp PE derating.

Open questions

?Does the 67.7% five-year earnings CAGR reflect a structural improvement in ANURAS's business model, or is it primarily driven by a favourable raw-material and end-market cycle that may not persist?
?Given D/E of 37.5 with a rising trend and FCF positive in only 1 year, how does the company plan to service and reduce debt if revenue growth normalises to sector-median levels?
?What explains the gap between high earnings growth and persistently low ROE — is it capital-intensive capacity expansion, accounting treatment, or a structural margin limitation in the product mix?
?At a trailing PE of 89.2 versus the sector-median PE of approximately 43 (based on peers), what earnings growth rate is required over the next 3–5 years to justify the current multiple, and what is the historical hit-rate for sustaining that pace?

Peer comparison: Chemicals

Ranks 3 of 6 on quality

Symbol	Name	P/E	ROE	Quality
ANURAS	Anupam Rasayan India Ltd.You're viewing	89.2	—	47
Industry avg	across 5 peers	51.8	+21.1%	45
PIDILITIND	Pidilite Industries Ltd.	61.2	+23.5%	66
SOLARINDS	Solar Industries India Ltd.	93.6	+31.3%	61
SRF	SRF Ltd.	43.5	+13.8%	41
COROMANDEL	Coromandel International Ltd.	28.2	+15.6%	30
PIIND	PI Industries Ltd.	32.6	—	25

Technical state

Current price

₹1,376.00

SMA 50

₹1,290.90

SMA 200

₹1,214.14

RSI (14)

65.2 (neutral)

From 52w high

-2.8%

1Y return

+53.4%

3M return

+4.9%

50-DMA

Above

200-DMA

Above

Algorithmic support levels

₹1,303.30

₹1,285.00

₹1,281.70

Algorithmic resistance levels

₹1,384.00

₹1,407.00

₹1,415.00

Risk flags

high
Debt-to-equity of 37.5 is the highest leverage reading among Chemicals sector peers in this dataset; the debt trend is classified as rising, and FCF was positive in only 1 of the available historical years — a combination that raises solvency concerns if revenue growth decelerates.
high
ROE data is null and 0 of the available years show ROE above 15%; the consistency score is 4, indicating that the 5-year earnings CAGR of 67.7% and revenue CAGR of 31.3% have not translated into measurable capital efficiency or positive free cash flow at scale.
medium
Trailing PE of 89.2 is the highest among the 6 ranked sector peers (ranked 5th of 6 on PE, i.e. most expensive); profit margin stands at 7.72% with no ROE benchmark available, so the valuation premium rests entirely on continued high-growth execution.
medium
Quality score of 47 ranks 3rd of 6 in the Chemicals peer group; PIDILITIND scores 66 and SOLARINDS 61, placing ANURAS in the lower-middle tier on composite quality relative to sector.
low
Zero news articles were retrieved for this run (total=0); no company-specific sentiment, management commentary, or event risk can be assessed from current data.

Cross-section contradictions

5-year revenue CAGR of 31.3% and earnings CAGR of 67.7% are among the stronger growth metrics in the peer set, yet FCF was positive in only 1 available year and ROE has never exceeded 15% — high reported earnings growth has not produced commensurate capital returns or cash conversion.
Stock is up 53.4% over 12 months, trades 13.2% above its 200-DMA (₹1,214), and sits just 2.8% below the 52-week high — strong price momentum — while D/E of 37.5 with a rising debt trend represents a materially stressed balance sheet.

Backtest a strategy on ANURAS Walk-forward test ANURASBrowse all stocks

For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.

Fundamentals & technicals: refreshed 25 Jun 2026 · refreshed daily at 01:00 IST

AI synthesis (narrative, snapshot, strengths/weaknesses, peer ranking): generated 17 May 2026 · rotates through NIFTY 500 every ~5 days